21 . November , 2017 - Tuesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Eplerenone

Big Image Pronouncation: (eh-PLER-en-ohn)
Class: Selective aldosterone receptor antagonists

Trade Names:
Inspra
- Tablets 25 mg
- Tablets 50 mg

Mechanism of Action

Pharmacology

Binds to mineralocorticoid receptor, blocking the binding of aldosterone.

Pharmacokinetics

Absorption

T max is 1.5 h.

Distribution

Approximately 50% is protein bound (primarily to alpha 1-acid glycoprotein). The Vd is 43 to 90 L (at steady state).

Metabolism

Metabolized by CYP3A4; no active metabolites formed.

Elimination

The elimination t ½ is approximately 4 to 6 h. Approximately 32% is excreted in feces and approximately 67% is excreted in urine. Less than 5% is excreted as unchanged drug. The plasma Cl is approximately 10 L/h.

Special Populations

Renal Function Impairment

AUC and C max increased 38% and 24%, respectively, in those with severe renal function impairment.

Hepatic Function Impairment

C max and AUC increased 3.6% and 42%, respectively, in those with moderate hepatic function impairment.

Elderly

C max increased 22% and AUC increased 45%.

Race

C max decreased 19% and AUC decreased 26% in black patients.

Indications and Usage

Treatment of hypertension; improve survival of stable patients with left ventricular systolic dysfunction and clinical evidence of CHF after an acute MI.

Contraindications

Patients with serum potassium greater than 5.5 mEq/L, type 2 diabetes with microalbuminuria, serum creatinine greater than 2 mg/dL in men or greater than 1.8 mg/dL in women, Ccr 30 mL/min or less, patients treated concurrently with potassium supplements, potassium-sparing diuretics (eg, spironolactone), or strong inhibitors of CYP3A4 (eg, ketoconazole).

Dosage and Administration

CHF Post-MI
Adults

PO Start with 25 mg every day and titrate to target dose of 50 mg every day within 4 wk as tolerated by the patient.

Dosage Adjustment in CHF
Adults

PO If serum potassium is less than 5 mEq/L, increase dose from 25 mg every day to 50 mg every day; if potassium levels are between 5 and 5.4 mEq/L, maintain dose; if potassium levels are between 5.5 and 5.9 mEq/L, decrease dose from 50 mg every day to 25 mg every day, or 25 mg every day to 25 mg every other day, or 25 mg every other day to withhold; if potassium levels are 6 mEq/L or greater, withhold the dose. When potassium levels have fallen below 5.5 mEq/L, restart dose at 25 mg every other day.

Hypertension
Adults

PO Initial dose 50 mg every day. The full therapeutic effect is seen within 4 wk. Patients with an inadequate BP response to 50 mg every day may be increased to 50 mg bid (max, 100 mg/day). Patients receiving weak CYP3A4 inhibitors (eg, saquinavir) start with 25 mg every day.

General Advice

Administer with or without food. Administer with food if GI upset occurs.

Storage/Stability

Store tablets at controlled room temperature (59° to 86°F).

Drug Interactions

ACE inhibitors and angiotensin II receptor antagonists

May increase the risk of hyperkalemia.

CYP3A4 inhibitors (eg, clarithromycin, nefazodone, ritonavir)

Elevated plasma levels of eplerenone, increasing the risk of side effects.

St. John's wort

Reduced plasma levels of eplerenone, decreasing the therapeutic effect.

Adverse Reactions

Cardiovascular

Angina pectoris; MI.

CNS

Headache; dizziness; fatigue.

GI

Diarrhea; abdominal pain.

Genitourinary

Albuminuria; abnormal vaginal bleeding; mastodynia, gynecomastia (men).

Metabolic

Hyponatremia; hypercholesterolemia; hypertriglyceridemia; increased BUN; increased uric acid; increase serum creatinine; increased ALT; hyperkalemia.

Respiratory

Coughing.

Miscellaneous

Flu-like symptoms.

Precautions

Pregnancy

Category B .

Lactation

Undetermined.

Children

Safety and efficacy not established.

Hyperkalemia

Hyperkalemia may occur. Risk can be minimized by patient selection, avoidance of certain drugs, and monitoring. Ensure that serum potassium is determined before starting therapy, within the first week, and at 1 mo after the start of therapy or dose adjustment. Periodically assess serum potassium thereafter.

Overdosage

Symptoms

Hypotension, hyperkalemia.

Patient Information

  • Advise patient to take every day as prescribed, without regard to meals. Advise patient to take with food if GI upset occurs.
  • Advise patient to try to take each dose at about the same time each day.
  • Inform patient that drug controls but does not cure hypertension and to continue taking it as prescribed even when BP is not elevated.
  • Caution patient not to change the dose or stop taking unless advised by health care provider.
  • Instruct patient to continue taking other BP medications as prescribed by health care provider.
  • Instruct patient in BP and pulse measurement skills.
  • Advise patient to monitor and record BP and pulse at home and to inform health care provider should abnormal measurements be noted. Also advise patient to take record of BP and pulse to each follow-up visit.
  • Instruct patient to lie or sit down if experiencing dizziness or lightheadedness when standing.
  • Emphasize to hypertensive patient importance of the following other modalities on BP: weight control, regular exercise, smoking cessation, moderate intake of alcohol and salt.
  • Caution patient not to take any prescription or OTC medications, salt substitutes, potassium supplements, or dietary supplements unless advised by health care provider.

Recent Drug Updates at DrugIndexOnline:





ardeparin ardeparin
Generic Name: ardeparin (are duh PEH rin) Brand Names: Normiflo What is ardeparin? Ardeparin was withdrawn from the U.S. market in March of 2000. Ardeparin is an anticoagulant (blood thinner). Ardeparin prevents the formation of blood clots. Ardeparin is used to prevent blood clot format more...

Asparaginase Asparaginase
Pronouncation: (ass-PAR-uh-jin-aze) Class: Enzyme Trade Names: Elspar - Powder for injection, lyophilized 10,000 units Kidrolase (Canada) Mechanism of Action Pharmacology Asparaginase contains the enzyme L-asparagine amidohydrolase. In a significant number of patients with acute leukemia, the malig more...

Calube Calube
Generic Name: docusate (DAH cue sate) Brand Names: Aqualax, Calube, Colace, Colace Micro-Enema, Correctol Softgel Extra Gentle, DC-240, Dialose, Diocto, Dioctocal, Dioctosoftez, Dioctyn, Dionex, Doc-Q-Lace, Docu Soft, Docucal, Doculax, Docusoft S, DOK, DOS, Doss-Relief, DSS, Ex-Lax Stool more...

Hydrap-ES Hydrap-ES
Generic Name: hydralazine/hydrochlorothiazide/reserpine (hye DRAL a zeen/hye droe klor oh THYE a zide/re SER peen) Brand Names: Diuretic Ap-Es, Hydrap-ES, Ser-Ap-Es, Serpazide, Tri-Hydroserpine, Uni Serp What is Hydrap-ES (hydralazine/hydrochlorothiazide/reserpine)? Hydralazine is a vas more...

Maxzide Maxzide
Generic Name: Triamterene/Hydrochlorothiazide Capsules and Tablets (trye-AM-ter-een/hye-droe-klor-oh-THYE-a-zide) Brand Name: Examples include Dyazide and MaxzideMaxzide can increase potassium levels in your body. This is more likely to occur in elderly patients, patients who are severely ill, more...

Miconazole Lotion Miconazole Lotion
Generic Name: Miconazole Lotion (mi-KON-a-zole) Brand Name: Zeasorb-AFMiconazole Lotion is used for:Treating athlete's foot, jock itch, or ringworm and relieving the itching, scaling, burning, and discomfort due to those conditions. It may also be used for other conditions as determined by your more...

Niaspan ER nicotinic acid Niaspan ER nicotinic acid
Generic Name: niacin (nicotinic acid) (NYE a sin (NIK oh TIN ik AS id)) Brand Names: B-3-50, B3-500-Gr, Niacin SR, Niacor, Niaspan ER, Nico-400, Nicobid Tempules, Nicolar, Slo-Niacin What is niacin? Niacin, also called nicotinic acid, is a B vitamin (vitamin B3). It occurs naturally in more...

Protopam Protopam
Generic Name: pralidoxime chloride Dosage Form: For injection Protopam Description Chemical name: 2-formyl-1-methylpyridinium chloride oxime. Available in the United States as Protopam Chloride, pralidoxime chloride is frequently referred more...